American Lecithin Company v. Rebmann

District Court, S.D. New York·Decided October 31, 2023·No. 1:12-cv-00929·Unknown

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK -----------------------------------------------------------------X AMERICAN LECITHIN CO., LIPOID GmbH, LIPOID LLC, and PHOSPHOLIPID GmbH,

Plaintiffs, ORDER

-against- 12-cv-929 (VSB) (JW)

CARSTEN MATTHIAS REBMANN,

Defendant; Counterclaim and Third-Party Plaintiff,

-against-

HERBERT REBMANN, LIPOID GRUNDSTUECKS GmbH, LIPOID VERWALTUNGS, GmbH, LIPOID AG, and COMPLECTOR AG,

Third-Party Defendants. -----------------------------------------------------------------X JENNIFER E. WILLIS, United States Magistrate Judge: This action has been pending for over a decade and was initially commenced on February 6, 2012. Dkt. No. 1. On February 13, 2014, the first answer with counterclaims was filed naming Third-Party Defendant Dr. Herbert Rebmann (“Dr. Rebmann”) as a party to this action. Dkt. No. 82. The instant dispute regarding sanctions arises from the alleged failure to preserve, search, and provide emails from Dr. Rebmann’s email account “dr.rebmann@lipoid.com” (the “Subject Email Account”). Dkt. No. 374. Defendant (together, the “Lipoid Group”) to show cause as to why the Court should not impose sanctions pursuant to its authority under Fed. R. Civ. P. 37(e) for spoliation and failure to preserve relevant information. Dkt. No. 380 (“OTSC”). In response to the OTSC, on October 18, 2023, the Lipoid Group submitted a memorandum of law asking that the Court impose no sanctions arguing that Dr.

Rebmann took reasonable measures to preserve, Dkt. No. 386 (“OTSC Resp.”), including a supporting declaration of Gregory F. Hauser, who is the Lipoid Group’s current counsel, Dkt. No. 386, Ex. 1 (“Hauser Decl.”); a declaration of Sherica Bryan, who was formerly employed by Plaintiff’s counsel, Dkt. No. 386, Ex. 7 (“Bryan Decl.”); a declaration from Andreas Zolodziej, who is a representative of Plaintiff Lipoid GmbH and Plaintiff Phospholipid GmbH, Dkt. No. 386, Ex. 8 (“Zolodziej Decl.”); a

declaration of Third-Party Defendant Dr. Herbert Rebmann, Dkt. No. 386, Ex. 9 (“Dr. Rebmann Decl.”); and a declaration of Dr. Rebmann’s wife, Birgit Rebmann, Dkt. No. 386, Ex. 10 (“B. Rebmann Decl.”). Defendant/Third-Party Plaintiff (“Matthias”) requests that this Court impose an adverse inference sanction for spoliation. Dkt. No. 392 (“Req. for Sanctions”). In a prior letter prompting the OTSC, Matthias requested sanctions, “including but not limited to case ending sanctions, an award of attorneys’ fees, or an adverse jury

instruction.” Dkt. No. 374. The Lipoid Group responded that Matthias had not met his burden of showing Dr. Rebmann acted with an intent to deprive Matthias of the information. Dkt. No. 403 (“Reply”). This Court, having heard the arguments on October 27, 2023, and reviewed the moving papers, is deeply troubled by the pattern and practice of dilatory discovery Court GRANTED the request for an adverse inference jury instruction, and awarded Matthias the fees and costs associated with the sanctions briefing.

BACKGROUND1 The operative amended complaint in this action was filed on April 10, 2012. Dkt. No. 12 (the “Am. Compl.”). Plaintiffs are a collection of companies that specialize in the lipoid business. Dkt. No. 340 at 3-4. Matthias was previously an officer of Plaintiff American Leicithin Company and Plaintiff Lipoid, LLC. Am. Compl. at ¶ 11. Plaintiff Lipoid GmbH and Plaintiff Phospholipid GmbH are related companies organized under the laws of Germany. Id. at ¶¶ 2,4. Plaintiffs’ lawsuit arises out of

a claim that Matthias registered various company domains in his own name and/or transferred various domains to his own name. Id. at ¶¶ 11-28. Specifically, Plaintiffs assert claims against Matthias arising out of the Anticybersquatting Consumer Protection Act (the “ACPA”), 15 U.S.C. § 1125(d). Am. Compl. at ¶ 6. Plaintiffs also have surviving claims for breach of fiduciary duty and conversion. Dkt. No. 400 at 3. Matthias has counterclaims for (i) wrongful termination, alleging in part that

his father Third-Party Defendant Dr. Rebmann orchestrated his termination because he would not file fraudulent tax returns and (ii) conversion against Dr. Rebmann for allegedly converting Matthias’s 10% equity interest in non-party Lipoid Grundstuecks GmbH (“Lipoid G”). Dkt. No. 400 at 8. The resolutions of Lipoid G indicated that Matthias’s interests were taken away “for cause” in part because American Lecithin Company. Dkt. No. 293 at 5. A. The Subject Email Account and Relevant History The Lipoid Group alleges that Dr. Rebmann began using the Subject Email Account after Matthias was terminated in August 2011. OTSC Resp. at 4. The domain associated with the Subject Email Account is controlled by Plaintiff Lipoid

GmbH, another named party in this action. Id. The Lipoid Group further states that due to confidentiality concerns, emails from the Subject Email Account were stored on Dr. Rebmann’s computer and not saved on the email server. Id. at 5. Dr. Rebmann alleges, “[i]n the time period of 2006-2012, [his] emails were never on the exchange server at Lipoid GmbH or Phospholipid GmbH, and were instead only on the laptop [he] was using, stored locally and not otherwise backed up.” Dr. Rebmann Decl. at 2.

Counsel for the Lipoid Group attests that on March 21, 2012, counsel received a letter from Matthias’s attorney’s raising the duty to preserve evidence and forwarded the letter to Dr. Rebmann the same day. OTSC Resp. at 6. Plaintiffs’ former counsel does not recall a specific conversation with Dr. Rebmann on preserving emails, but alleges that their standard practice was to have a conversation with clients about document preservation. Bryan Decl. On February 20, 2014, Matthias sent his first request for production of

documents to Dr. Rebmann, which included a direction to “preserve all relevant and potentially relevant information” (bold in the original text). Req. for Sanctions at 5. Dr. Rebmann was deposed on April 29, 2015, and he testified that he had relevant emails and documents on his personal computer. Id. at 4. On May 20, 2015, the Lipoid Group’s counsel received a follow-up communication for documents returns that [Matthias] allegedly refused or failed to file.” Id., Ex. C at 2. From July 3, 2014 to September 30, 2017, discovery on the counterclaims was stayed intermittently pending the Court’s resolution of various motions to dismiss in this action. Reply at 3-4. During a hearing on sanctions on October 27, 2023, when asked whether Dr. Rebmann’s email retention procedures changed at all in response to the

litigation notice, counsel for the Lipoid Group responded that no change in retention practices occurred.2 Dr. Rebmann alleges he “had a series of laptops [since 2011]. One ha[d] been destroyed, another lost, and one damaged. As a result, only a limited number of [his] emails to and from [Matthias] during the relevant time period [had] been saved.” Dkt. No. 377, Ex. 2 at 2. Dr. Rebmann claims he lost the first relevant laptop in 2016.

Dr. Rebmann Decl. at 3. On May 24, 2023, this Court heard oral argument regarding a discovery dispute and discussed relevant tax issues with the Parties. See Transcript at Dkt. No. 340. On May 24, 2023, this Court ordered Plaintiffs to “turn over any responsive documents in their possession related to the tax issues” discussed in the case. Dkt. No. 330 at 2. On August 25, 2023, the Court denied Matthias’s request to compel certain communications, but directed Plaintiffs “to produce the relevant tax emails

by September 1, 2023.” Dkt. No. 350.

Free access — add to your briefcase to read the full text and ask questions with AI

American Lecithin Company v. Rebmann, (S.D.N.Y. 2023).

American Lecithin Company v. Rebmann (American Lecithin Company v. Rebmann) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

West v. Goodyear Tire & Rubber Co.
167 F.3d 776 (Second Circuit, 1999)
Ottoson v. SMBC Leasing & Finance, Inc.
268 F. Supp. 3d 570 (S.D. New York, 2017)
Moody v. CSX Transportation, Inc.
271 F. Supp. 3d 410 (W.D. New York, 2017)
Zubulake v. UBS Warburg LLC
220 F.R.D. 212 (S.D. New York, 2003)
Zubulake v. UBS Warburg LLC
229 F.R.D. 422 (S.D. New York, 2004)
R.F.M.A.S., Inc. v. So
271 F.R.D. 13 (S.D. New York, 2010)